Related Experiment Video
Updated: Aug 6, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
COVID-19 and sickle cell disease in Bahrain
Abdulkarim AbdulRahman1, Salman AlAli2, Omar Yaghi2
1Bahrain National Taskforce to Combat COVID-19, Mohammed Bin Khalifa Cardiac Centre, Bahrain.
Introduction:
Coronavirus disease 2019 (COVID-19) is caused by a newly identified strain of the coronavirus family that has been shown to affect the hemoglobin beta chain, the same chain that has sickle cell disease (SCD) mutation. This study was undertaken to see if COVID-19 infection increased disease severity in patients with SCD.
Methods:
Mass screening of the Bahraini population was undertaken between February and April 2020.
Results:
A total of 38,092 Bahraini people were tested for COVID-19 during this period; 378 (1%) were SCD patients. Six patients with SCD had COVID-19 (1.6%): three remained asymptomatic, two had mild symptoms and one required oxygen therapy. The SCD patients had a similar average length of stay when compared with non-SCD COVID-19 patients (10.7 days).
Conclusion:
The infection rate, clinical course and viral clearance seen for the SCD patients with COVID-19 were no different to those without SCD.
More Related Videos
Related Concept Videos
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Infectious Diseases and Their Occurrence
Coronavirus
Respiratory Syncytial Virus Disease

